… In COVID-19, TNF-α-mediated … with COVID-19 morbidity and mortality. In addition, this
review also proposes the potential of TNF-α as a biomarker for the prognosis of severe COVID-19 …

… COVID-19. This study aims to characterize serum cytokines of patients with severe or critical
COVID-19… Compared with patients in severe COVID-19, those who in critical COVID-19 had …

… Lymphopenia is common in severe coronavirus disease (COVID-19), and here we show it is
… -α (tumor necrosis factor-α) in CD4 + T cells from patients with severe COVID-19 and further …

… for the distribution of covariates in all patients with COVID-19, based on data of two health
care systems with systematic report of COVID-19. However, this analysis was limited to …

… COVID-19, thus highlighting its potential as a biomarker and therapeutic target for COVID-19. …
cytokines with severity and mortality of COVID-19 by systematic review and meta-analysis. …

… tumor necrosis factor inhibitors (TNFis) or methotrexate are at increased risk of COVID-19–…
given limitations of COVID-19 confirmatory testing, although COVID-19–specific diagnoses …

… the potential of anti-tumor necrosis factor (TNF) therapy to inhibit development of a cytokine
storm in patients with coronavirus disease 2019 (COVID-19). Following this Comment, I write …

… of coronavirus disease 2019 (COVID-19) and its complications among patients with psoriasis
treated by tumor necrosis … We aimed to assess the risk of COVID-19 infection, COVID-19-…

… of tumor necrosis factor-α (TNF-α) and its receptors in coronavirus disease 2019 (COVID-19…
(rs1061622 and rs3397) variants with COVID-19 severity, assessed as invasive mechanical …

… Inflammatory mediators such as IL-2, IL-6, and tumor necrosis factor (TNF) are also infiltrated
by inflammatory cells into the lungs due to increased production, destroying lung structure (…